.svg){kind=small}
Dec-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Stigma Grow has demonstrated varied performance across different categories and provinces. In Alberta, their standing in the Capsules category remained relatively stable, maintaining a top 4 position for most of the last four months of 2025. However, there was a notable decline in sales from September to December. In the Concentrates category, Stigma Grow showed an upward trend, moving from 14th to 8th position, with a significant increase in sales, indicating strong growth potential. Conversely, their performance in the Flower category was inconsistent, as they failed to maintain a top 30 position consistently, only appearing in October and December. This suggests a need for strategic adjustments in this segment to capture more market share.
In British Columbia, Stigma Grow's entrance into the Capsules category in December with a 7th place ranking indicates a promising start. Their performance in the Concentrates category also showed a positive trajectory, climbing from 29th place in October to 15th by December, despite fluctuating sales volumes. Meanwhile, in Ontario, Stigma Grow exhibited stability in the Capsules category, consistently ranking around the 9th to 11th positions, with an overall increase in sales from September to December. This steady performance in Ontario suggests a solid foothold in the Capsules market, which could serve as a foundation for expanding their presence in other categories and regions.
Competitive Landscape
In the Alberta concentrates market, Stigma Grow has shown a notable upward trajectory in its rankings and sales from September to December 2025. Initially ranked 14th in September, Stigma Grow improved its position to 8th by December, reflecting a strong growth in market presence. This positive trend is accompanied by a significant increase in sales, indicating effective market strategies and consumer acceptance. In comparison, Virtue Cannabis experienced fluctuations, peaking at 7th in October but dropping to 9th by December. Meanwhile, Vortex Cannabis Inc. maintained a relatively stable position, hovering around the 8th to 10th ranks, although their sales did not match the growth seen by Stigma Grow. Nugz (Canada) made a remarkable leap from being unranked in September to consistently holding the 6th position from November onwards, suggesting a strong market entry. The Goo! also demonstrated consistent performance, maintaining a top 10 position throughout the period. These dynamics highlight Stigma Grow's competitive edge and potential for continued growth in the Alberta concentrates market.
Notable Products
In December 2025, Stigma Grow's top-performing product was Phoenix Tears RSO (1g) in the Concentrates category, maintaining its number one rank from previous months with a notable sales figure of 4412 units. Indica RSO Capsules 25-Pack (250mg) held the second position consistently from November, with December sales reaching 3377 units. CBD Softgels 15-Pack (750mg CBD) continued its steady performance, retaining the third rank across the last four months. Rippin Razz 2.0 Shatter (4g) returned to the rankings in December, securing the fourth position after being unranked in November. Phoenix Tears Honey Oil (1g) made an entry as the fifth-ranked product, indicating a new addition to the top-performing list.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
